Tenders Are Invited For Pharmaceutical Products - Open House Medicinal Products Departments On The Active Ingredient Emtricitabine, Tenofovirdisoproxil And Rilpivirin, Atc J05ar08

Pharmaceutical Products - Open House Medicinal Products Departments On The Active Ingredient Emtricitabine, Tenofovirdisoproxil And Rilpivirin, Atc J05ar08. The Aok Rhineland -Palatinate/Saarland - The Health Insurance Company Offers All Interested Pharmaceutical Companies Without A Selection Decision. The Contractual Conclusions Are Made As Part Of An Open House Model. The Contracts Offered Are Not Exclusive; Contracts With All Market Participants (Pharmaceutical Companies) Are Desired By The Aok Rhineland -Palatinate/Saarland - The Health Insurance Company. In The Open House Model, Uniform Conditions Apply To All Participants. Contract Content, Conditions And Access Procedures Are Uniform - Individual Negotiations Are Not Conducted. The Contract Term Is A Maximum Of 24 Months, The Earliest Start Of The Contract Is May 1St, 2025. All Contracts End At The Latest 24 Months After The Day Of The Earliest Contract, Regardless Of The Date Of The Respective Contract. Access Or A Contract Can Be Concluded Within The 24-Month Period For The First Of Each Month. There Is A Right Of Termination For 6 Weeks At The End Of The Month In Accordance With The Provisions Of The Contract. Further Information On The Termination Options Is Included In The Contract Documents. The Aok Rhineland-Palatinate/Saarland-The Health Insurance Company Reserves The Right To Replace The Non-Exclusive Open House Discount Contracts With Exclusive Discount Contracts During The Contract Period As Part Of Europe-Wide Tender Procedures. With The Entry Into Force, The Open House Contracts Are Terminated In Accordance With The Contractual Regulation, I.E. The Open House Contracts Will End Automatically. Interested Pharmaceutical Companies Can Request The Participation Documents And The Contract Documents At The Contact Address Mentioned. Contracts For The Above -Mentioned Active Ingredient Will Be Concluded For The First Time With Effect On 01.05.2025. Interested Parties Who Would Like To Become A Contractual Partner For This Date Must Submit The Contract Documents To Be Submitted By March 31, 2025 At The Aok Rhineland -Palatinate/Saarland. It Depends On Access To The Aok Rhineland -Palatinate/Saarland - The Health Fund. Note: The First Surcharge In This Procedure Will Be Granted 10 Calendar Days After The Publication Of This Eu Announcement In The Official Journal. Later Conclusions Are Possible During The 24-Month Maximum Term For The First One Month. In The Case Of Interested Parties Who Want To Become A Contractual Partner At These Follow -Up Appointments, The Receipt Of The Contract Documents, Including The Investments, Must Be Submitted To The Previous Month Of The Desired Start Of The Contract (E.G. Input 30.04..06.). The Exact Entrance Periods Will Be Announced With The Contract Documents. The Present Publication Is Not The Allocation Of A Public Mandate Within The Meaning Of The Award Coordination Directive 2014/24/Eu Of European Parlam